311 related articles for article (PubMed ID: 21247310)
1. Effect of occult metastases on survival in node-negative breast cancer.
Weaver DL; Ashikaga T; Krag DN; Skelly JM; Anderson SJ; Harlow SP; Julian TB; Mamounas EP; Wolmark N
N Engl J Med; 2011 Feb; 364(5):412-21. PubMed ID: 21247310
[TBL] [Abstract][Full Text] [Related]
2. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study.
Weaver DL; Krag DN; Ashikaga T; Harlow SP; O'Connell M
Cancer; 2000 Mar; 88(5):1099-107. PubMed ID: 10699901
[TBL] [Abstract][Full Text] [Related]
3. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.
Krag DN; Anderson SJ; Julian TB; Brown AM; Harlow SP; Costantino JP; Ashikaga T; Weaver DL; Mamounas EP; Jalovec LM; Frazier TG; Noyes RD; Robidoux A; Scarth HM; Wolmark N
Lancet Oncol; 2010 Oct; 11(10):927-33. PubMed ID: 20863759
[TBL] [Abstract][Full Text] [Related]
4. Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases.
de Boniface J; Filtenborg Tvedskov T; Rydén L; Szulkin R; Reimer T; Kühn T; Kontos M; Gentilini OD; Olofsson Bagge R; Sund M; Lundstedt D; Appelgren M; Ahlgren J; Norenstedt S; Celebioglu F; Sackey H; Scheel Andersen I; Hoyer U; Nyman PF; Vikhe Patil E; Wieslander E; Dahl Nissen H; Alkner S; Andersson Y; Offersen BV; Bergkvist L; Frisell J; Christiansen P; ;
N Engl J Med; 2024 Apr; 390(13):1163-1175. PubMed ID: 38598571
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases.
de Boer M; van Dijck JA; Bult P; Borm GF; Tjan-Heijnen VC
J Natl Cancer Inst; 2010 Mar; 102(6):410-25. PubMed ID: 20190185
[TBL] [Abstract][Full Text] [Related]
6. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of occult metastases and isolated tumor cells in sentinel and non-sentinel lymph nodes in early breast cancer patients: serial step section analysis with long-term follow-up.
Takeshita T; Tsuda H; Moriya T; Yamasaki T; Asakawa H; Ueda S; Sato K; Aida S; Tamai S; Matsubara O; Hase K; Yamamoto J
Ann Surg Oncol; 2012 Apr; 19(4):1160-6. PubMed ID: 21989659
[TBL] [Abstract][Full Text] [Related]
8. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
Giuliano AE; Ballman KV; McCall L; Beitsch PD; Brennan MB; Kelemen PR; Ollila DW; Hansen NM; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Morrow M
JAMA; 2017 Sep; 318(10):918-926. PubMed ID: 28898379
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
10. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of occult metastases in axillary sentinel lymph nodes of breast carcinoma.
Amir AS; Azar FP; Sahram N; Naser FM; Na'ma MR; Farid F; Khatoon AN; Ramin S; Ali TK
Pol J Pathol; 2012 Mar; 63(1):40-4. PubMed ID: 22535605
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection.
Kamath VJ; Giuliano R; Dauway EL; Cantor A; Berman C; Ku NN; Cox CE; Reintgen DS
Arch Surg; 2001 Jun; 136(6):688-92. PubMed ID: 11387010
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer.
Pargaonkar AS; Beissner RS; Snyder S; Speights VO
Arch Pathol Lab Med; 2003 Jun; 127(6):701-5. PubMed ID: 12741893
[TBL] [Abstract][Full Text] [Related]
14. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A
Breast J; 2006; 12(4):294-301. PubMed ID: 16848838
[TBL] [Abstract][Full Text] [Related]
15. Observational study of axilla treatment for breast cancer patients with 1-3 positive micrometastases or macrometastases in sentinel lymph nodes.
Oba MS; Imoto S; Toh U; Wada N; Kawada M; Kitada M; Masuda N; Taguchi T; Minami S; Jinno H; Sakamoto J; Morita S;
Jpn J Clin Oncol; 2014 Sep; 44(9):876-9. PubMed ID: 25030214
[TBL] [Abstract][Full Text] [Related]
16. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.
Nos C; Harding-MacKean C; Fréneaux P; Trie A; Falcou MC; Sastre-Garau X; Clough KB
Br J Surg; 2003 Nov; 90(11):1354-60. PubMed ID: 14598414
[TBL] [Abstract][Full Text] [Related]
17. Occult axillary lymph node metastases do not have prognostic significance in early stage breast cancer.
Wu Y; Mittendorf EA; Kelten C; Tucker SL; Wei W; Middleton LP; Broglio K; Buchholz TA; Hunt KK; Sahin AA
Cancer; 2012 Mar; 118(6):1507-14. PubMed ID: 22009292
[TBL] [Abstract][Full Text] [Related]
18. Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer.
Giuliano AE; Hawes D; Ballman KV; Whitworth PW; Blumencranz PW; Reintgen DS; Morrow M; Leitch AM; Hunt KK; McCall LM; Abati A; Cote R
JAMA; 2011 Jul; 306(4):385-93. PubMed ID: 21791687
[TBL] [Abstract][Full Text] [Related]
19. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer.
Veronesi U; Paganelli G; Viale G; Luini A; Zurrida S; Galimberti V; Intra M; Veronesi P; Robertson C; Maisonneuve P; Renne G; De Cicco C; De Lucia F; Gennari R
N Engl J Med; 2003 Aug; 349(6):546-53. PubMed ID: 12904519
[TBL] [Abstract][Full Text] [Related]
20. Minimal prognostic significance of sentinel lymph node metastasis in patients with cT1-2 and cN0 breast cancer.
Shigematsu H; Nishina M; Yasui D; Hirata T; Ozaki S
World J Surg Oncol; 2019 Feb; 17(1):41. PubMed ID: 30797231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]